Hosted on MSN15m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
pharmaphorum14m
J&J's Spravato gets another lift with new FDA approval
The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...
pharmaphorum7m
HPV self-collection: A step closer to eliminating cervical cancer
Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.